Tilman Schlothauer

3.1k total citations
45 papers, 2.2k citations indexed

About

Tilman Schlothauer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Tilman Schlothauer has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 39 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Immunology. Recurrent topics in Tilman Schlothauer's work include Monoclonal and Polyclonal Antibodies Research (39 papers), Protein purification and stability (25 papers) and Glycosylation and Glycoproteins Research (24 papers). Tilman Schlothauer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (39 papers), Protein purification and stability (25 papers) and Glycosylation and Glycoproteins Research (24 papers). Tilman Schlothauer collaborates with scholars based in Germany, Switzerland and United States. Tilman Schlothauer's co-authors include Dietmar Reusch, Patrick Bulau, Thomas Emrich, Bernd Bukau, Kürşad Turgay, David A. Dougan, Axel Mogk, Marco Thomann, Christian Spick and Alexander Knaupp and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Tilman Schlothauer

44 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tilman Schlothauer Germany	23	1.6k	1.3k	570	242	188	45	2.2k
Arvind Rajpal United States	28	1.5k 0.9×	1.4k 1.1×	874 1.5×	590 2.4×	55 0.3×	55	2.7k
Stephen J. Demarest United States	25	1.6k 1.0×	1.0k 0.8×	364 0.6×	309 1.3×	86 0.5×	50	2.0k
Alain Balland United States	24	1.8k 1.1×	1.2k 0.9×	279 0.5×	153 0.6×	398 2.1×	46	2.2k
Karli R. Reiding Netherlands	26	2.0k 1.2×	748 0.6×	801 1.4×	121 0.5×	522 2.8×	60	2.5k
Jodie L. Abrahams Australia	21	1.5k 0.9×	401 0.3×	408 0.7×	114 0.5×	304 1.6×	32	1.9k
Michael T. Stumpp Switzerland	18	1.7k 1.0×	1.0k 0.8×	224 0.4×	310 1.3×	57 0.3×	26	2.3k
B Adamczyk Ireland	22	1.5k 0.9×	555 0.4×	556 1.0×	104 0.4×	229 1.2×	46	1.9k
Davinder Gill United States	26	822 0.5×	641 0.5×	783 1.4×	185 0.8×	80 0.4×	50	1.8k
Yoshiki Narimatsu Denmark	29	2.2k 1.4×	312 0.2×	762 1.3×	257 1.1×	196 1.0×	60	2.8k
Daryl L. Fernandes United Kingdom	19	1.6k 1.0×	835 0.6×	668 1.2×	68 0.3×	276 1.5×	25	2.1k

Countries citing papers authored by Tilman Schlothauer

Since Specialization

Citations

This map shows the geographic impact of Tilman Schlothauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Schlothauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Schlothauer more than expected).

Fields of papers citing papers by Tilman Schlothauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilman Schlothauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Schlothauer. The network helps show where Tilman Schlothauer may publish in the future.

Co-authorship network of co-authors of Tilman Schlothauer

This figure shows the co-authorship network connecting the top 25 collaborators of Tilman Schlothauer. A scholar is included among the top collaborators of Tilman Schlothauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilman Schlothauer. Tilman Schlothauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nilsen, Jeannette, Thomas U. Greiner, Maria Stensland, et al.. (2025). Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end. Communications Biology. 8(1). 810–810. 3 indexed citations

Gstöttner, Christoph, Michaela Hook, Feng Yang, et al.. (2024). Benchmarking glycoform-resolved affinity separation – mass spectrometry assays for studying FcγRIIIa binding. Frontiers in Immunology. 15. 1347871–1347871. 4 indexed citations

Marshall, Michael J., Alexander Knaupp, Christian Spick, et al.. (2023). Development of C1q Affinity Chromatography for the Study of C1q–IgG Interactions. The Journal of Immunology. 210(11). 1837–1848. 2 indexed citations

Reusch, Dietmar, Alexander Knaupp, Saeed Izadi, et al.. (2023). Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes. Frontiers in Immunology. 14. 1260446–1260446. 2 indexed citations

Larivière, Laurent, Thomas von Hirschheydt, Tilman Schlothauer, et al.. (2023). End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations. International Journal of Pharmaceutics X. 5. 100157–100157. 2 indexed citations

Gjølberg, Torleif Tollefsrud, Rahel Frick, Stian Foss, et al.. (2022). Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life. Communications Biology. 5(1). 832–832. 14 indexed citations

Gstöttner, Christoph, Alexander Knaupp, Gestur Vidarsson, et al.. (2022). Affinity capillary electrophoresis – mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner. Frontiers in Immunology. 13. 980291–980291. 10 indexed citations

Duivelshof, Bastiaan L., Julien Camperi, Tilman Schlothauer, et al.. (2022). Extending the performance of FcRn and FcγRIIIa affinity liquid chromatography for protein biopharmaceuticals. Journal of Chromatography A. 1682. 463518–463518. 6 indexed citations

Grevys, Algirdas, Rahel Frick, Karine Flem‐Karlsen, et al.. (2022). Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life. iScience. 25(2). 103746–103746. 35 indexed citations

10.

Knaupp, Alexander, Arnoud H. de Ru, Peter A. van Veelen, et al.. (2021). Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography–mass spectrometry. mAbs. 13(1). 1982847–1982847. 9 indexed citations

11.

Grevys, Algirdas, Jeannette Nilsen, Kine Marita Knudsen Sand, et al.. (2018). A human endothelial cell-based recycling assay for screening of FcRn targeted molecules. Nature Communications. 9(1). 621–621. 64 indexed citations

12.

Wang, Ka, Tilman Schlothauer, Angelika Lahr, et al.. (2017). An apparent clinical pharmacokinetic drug–drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism. Cancer Chemotherapy and Pharmacology. 79(4). 661–671. 8 indexed citations

13.

Cymer, Florian, Marco Thomann, Harald Wegele, et al.. (2017). Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131). Biologicals. 50. 125–128. 23 indexed citations

14.

Wartha, Katharina, Ekkehard Moessner, Ralf J. Hosse, et al.. (2016). XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer. mAbs. 8(4). 811–827. 27 indexed citations

15.

Schlothauer, Tilman, Sylvia Herter, Claudia Ferrara, et al.. (2016). Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. Protein Engineering Design and Selection. 29(10). 457–466. 230 indexed citations

16.

Thomann, Marco, et al.. (2015). Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. PLoS ONE. 10(12). e0143520–e0143520. 82 indexed citations

17.

Thomann, Marco, et al.. (2015). In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity. PLoS ONE. 10(8). e0134949–e0134949. 180 indexed citations

18.

Diepold, Katharina, Boris Zimmermann, A. Petzold, et al.. (2012). Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures. PLoS ONE. 7(1). e30295–e30295. 95 indexed citations

19.

Ji, Changhua, Erhard Kopetzki, Andreas Jekle, et al.. (2008). CD4-anchoring HIV-1 Fusion Inhibitor with Enhanced Potency and in Vivo Stability. Journal of Biological Chemistry. 284(8). 5175–5185. 21 indexed citations

20.

Schlothauer, Tilman, Axel Mogk, David A. Dougan, Bernd Bukau, & Kürşad Turgay. (2003). MecA, an adaptor protein necessary for ClpC chaperone activity. Proceedings of the National Academy of Sciences. 100(5). 2306–2311. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact